Clinical Trial

A Trial of HRS-3095 in Healthy Volunteers

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-08
Trial Details
NCT Number NCT07686484
Lead Sponsor Atridia Pty Ltd.
Conditions Chronic Spontaneous Urticaria
Enrollment 36 participants
Start Date 2026-07-27
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-07